SML ISUZU Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 15, 2025, 9:09 pm

Quick Insight

SML ISUZU Ltd's current market dynamics reveal a company with a high P/E ratio of 40.1, indicating investor optimism, supported by robust fundamentals such as a strong ROE of 36.4% and a healthy ROCE of 27.1%. Despite a relatively low OPM of 12%, the company's Net Profit stands at 122 Cr., showcasing operational efficiency. With a significant promoter holding of 43.96% and institutional ownership at 15.32%, there is a solid foundation of confidence in the company. Furthermore, the P/BV ratio of 5.92x suggests the stock may be trading at a premium. Investors should closely monitor the company's ability to manage its borrowings of ₹327Cr and maintain its healthy ICR of 8.05x to ensure sustained growth and profitability in the competitive Auto – LCVs/HCVs industry.

Competitors of SML ISUZU Ltd

All Competitor Stocks of SML ISUZU Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:25 am

Below is a detailed analysis of the quarterly data for SML ISUZU Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 846.00 Cr.. The value appears strong and on an upward trend. It has increased from 771.00 Cr. (Mar 2025) to 846.00 Cr., marking an increase of 75.00 Cr..
• For Expenses, as of Jun 2025, the value is 741.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 681.00 Cr. (Mar 2025) to 741.00 Cr., marking an increase of 60.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 105.00 Cr.. The value appears strong and on an upward trend. It has increased from 90.00 Cr. (Mar 2025) to 105.00 Cr., marking an increase of 15.00 Cr..
• For OPM %, as of Jun 2025, the value is 12.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00%.
• For Other Income, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 19.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 25.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 67.00 Cr., marking an increase of 14.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 46.27. The value appears strong and on an upward trend. It has increased from 36.59 (Mar 2025) to 46.27, marking an increase of 9.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:59 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 2:19 pm

Below is a detailed analysis of the balance sheet data for SML ISUZU Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 368.00 Cr.. The value appears strong and on an upward trend. It has increased from 271.00 Cr. (Mar 2024) to 368.00 Cr., marking an increase of 97.00 Cr..
• For Borrowings, as of Mar 2025, the value is 327.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 421.00 Cr. (Mar 2024) to 327.00 Cr., marking a decrease of 94.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 590.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 506.00 Cr. (Mar 2024) to 590.00 Cr., marking an increase of 84.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,299.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,213.00 Cr. (Mar 2024) to 1,299.00 Cr., marking an increase of 86.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 338.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2024) to 338.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 31.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 919.00 Cr.. The value appears strong and on an upward trend. It has increased from 861.00 Cr. (Mar 2024) to 919.00 Cr., marking an increase of 58.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,299.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,213.00 Cr. (Mar 2024) to 1,299.00 Cr., marking an increase of 86.00 Cr..

Notably, the Reserves (368.00 Cr.) exceed the Borrowings (327.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for SML ISUZU Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 84.08. This value is within the healthy range. It has increased from 74.54 (Mar 24) to 84.08, marking an increase of 9.54.
• For Diluted EPS (Rs.), as of Mar 25, the value is 84.08. This value is within the healthy range. It has increased from 74.54 (Mar 24) to 84.08, marking an increase of 9.54.
• For Cash EPS (Rs.), as of Mar 25, the value is 117.42. This value is within the healthy range. It has increased from 107.33 (Mar 24) to 117.42, marking an increase of 10.09.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 264.27. It has increased from 197.25 (Mar 24) to 264.27, marking an increase of 67.02.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 264.27. It has increased from 197.25 (Mar 24) to 264.27, marking an increase of 67.02.
• For Dividend / Share (Rs.), as of Mar 25, the value is 18.00. This value exceeds the healthy maximum of 3. It has increased from 16.00 (Mar 24) to 18.00, marking an increase of 2.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,656.76. It has increased from 1,516.65 (Mar 24) to 1,656.76, marking an increase of 140.11.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 166.17. This value is within the healthy range. It has increased from 127.30 (Mar 24) to 166.17, marking an increase of 38.87.
• For PBIT / Share (Rs.), as of Mar 25, the value is 132.78. This value is within the healthy range. It has increased from 94.48 (Mar 24) to 132.78, marking an increase of 38.30.
• For PBT / Share (Rs.), as of Mar 25, the value is 112.14. This value is within the healthy range. It has increased from 73.52 (Mar 24) to 112.14, marking an increase of 38.62.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 84.03. This value is within the healthy range. It has increased from 74.51 (Mar 24) to 84.03, marking an increase of 9.52.
• For PBDIT Margin (%), as of Mar 25, the value is 10.02. This value is within the healthy range. It has increased from 8.39 (Mar 24) to 10.02, marking an increase of 1.63.
• For PBIT Margin (%), as of Mar 25, the value is 8.01. This value is below the healthy minimum of 10. It has increased from 6.22 (Mar 24) to 8.01, marking an increase of 1.79.
• For PBT Margin (%), as of Mar 25, the value is 6.76. This value is below the healthy minimum of 10. It has increased from 4.84 (Mar 24) to 6.76, marking an increase of 1.92.
• For Net Profit Margin (%), as of Mar 25, the value is 5.07. This value is within the healthy range. It has increased from 4.91 (Mar 24) to 5.07, marking an increase of 0.16.
• For Return on Networth / Equity (%), as of Mar 25, the value is 31.79. This value is within the healthy range. It has decreased from 37.77 (Mar 24) to 31.79, marking a decrease of 5.98.
• For Return on Capital Employeed (%), as of Mar 25, the value is 36.43. This value is within the healthy range. It has increased from 34.81 (Mar 24) to 36.43, marking an increase of 1.62.
• For Return On Assets (%), as of Mar 25, the value is 9.36. This value is within the healthy range. It has increased from 8.89 (Mar 24) to 9.36, marking an increase of 0.47.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.16. This value is below the healthy minimum of 0.2. It has increased from 0.14 (Mar 24) to 0.16, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.84. This value is within the healthy range. It has decreased from 1.46 (Mar 24) to 0.84, marking a decrease of 0.62.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.91. It has decreased from 2.04 (Mar 24) to 1.91, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 1.17. This value is below the healthy minimum of 1.5. It has increased from 1.01 (Mar 24) to 1.17, marking an increase of 0.16.
• For Quick Ratio (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has increased from 0.29 (Mar 24) to 0.42, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.98. This value is below the healthy minimum of 4. It has decreased from 3.50 (Mar 24) to 2.98, marking a decrease of 0.52.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 8.05. This value is within the healthy range. It has increased from 6.07 (Mar 24) to 8.05, marking an increase of 1.98.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.07. This value is within the healthy range. It has increased from 4.55 (Mar 24) to 5.07, marking an increase of 0.52.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,567.42. It has decreased from 3,134.22 (Mar 24) to 2,567.42, marking a decrease of 566.80.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.07. This value is within the healthy range. It has decreased from 1.43 (Mar 24) to 1.07, marking a decrease of 0.36.
• For EV / EBITDA (X), as of Mar 25, the value is 10.67. This value is within the healthy range. It has decreased from 17.00 (Mar 24) to 10.67, marking a decrease of 6.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.94, marking a decrease of 0.32.
• For Price / BV (X), as of Mar 25, the value is 5.92. This value exceeds the healthy maximum of 3. It has decreased from 9.69 (Mar 24) to 5.92, marking a decrease of 3.77.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.94. This value is below the healthy minimum of 1. It has decreased from 1.26 (Mar 24) to 0.94, marking a decrease of 0.32.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness